Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_24h_versus_single_gel_24h.class.cls #double_gel_24h_versus_single_gel_24h_repos |
Phenotype | class.cls#double_gel_24h_versus_single_gel_24h_repos |
Upregulated in class | double_gel_24h |
GeneSet | SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY |
Enrichment Score (ES) | 0.46005985 |
Normalized Enrichment Score (NES) | 1.9747287 |
Nominal p-value | 0.0 |
FDR q-value | 0.032626554 |
FWER p-Value | 0.427 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | CHRNA7 | CHRNA7 Entrez,  Source | cholinergic receptor, nicotinic, alpha 7 | 107 | 0.175 | 0.0258 | Yes |
2 | AQP9 | AQP9 Entrez,  Source | aquaporin 9 | 232 | 0.144 | 0.0443 | Yes |
3 | KCNB2 | KCNB2 Entrez,  Source | potassium voltage-gated channel, Shab-related subfamily, member 2 | 483 | 0.119 | 0.0484 | Yes |
4 | KCNJ4 | KCNJ4 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 4 | 546 | 0.114 | 0.0658 | Yes |
5 | NOX1 | NOX1 Entrez,  Source | NADPH oxidase 1 | 560 | 0.113 | 0.0867 | Yes |
6 | SCN2B | SCN2B Entrez,  Source | sodium channel, voltage-gated, type II, beta | 689 | 0.105 | 0.0973 | Yes |
7 | CACNG2 | CACNG2 Entrez,  Source | calcium channel, voltage-dependent, gamma subunit 2 | 693 | 0.104 | 0.1173 | Yes |
8 | CLCNKB | CLCNKB Entrez,  Source | chloride channel Kb | 710 | 0.104 | 0.1362 | Yes |
9 | CLCN1 | CLCN1 Entrez,  Source | chloride channel 1, skeletal muscle (Thomsen disease, autosomal dominant) | 715 | 0.103 | 0.1559 | Yes |
10 | TRPV5 | TRPV5 Entrez,  Source | transient receptor potential cation channel, subfamily V, member 5 | 903 | 0.095 | 0.1603 | Yes |
11 | RYR2 | RYR2 Entrez,  Source | ryanodine receptor 2 (cardiac) | 917 | 0.095 | 0.1777 | Yes |
12 | KCNJ14 | KCNJ14 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 14 | 936 | 0.094 | 0.1945 | Yes |
13 | CHRNA3 | CHRNA3 Entrez,  Source | cholinergic receptor, nicotinic, alpha 3 | 992 | 0.092 | 0.2081 | Yes |
14 | KCNN3 | KCNN3 Entrez,  Source | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 | 1040 | 0.090 | 0.2220 | Yes |
15 | CACNA2D1 | CACNA2D1 Entrez,  Source | calcium channel, voltage-dependent, alpha 2/delta subunit 1 | 1054 | 0.089 | 0.2384 | Yes |
16 | KCNJ6 | KCNJ6 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 6 | 1102 | 0.087 | 0.2517 | Yes |
17 | P2RX1 | P2RX1 Entrez,  Source | purinergic receptor P2X, ligand-gated ion channel, 1 | 1200 | 0.084 | 0.2605 | Yes |
18 | ACCN1 | ACCN1 Entrez,  Source | amiloride-sensitive cation channel 1, neuronal (degenerin) | 1306 | 0.080 | 0.2681 | Yes |
19 | TRPC3 | TRPC3 Entrez,  Source | transient receptor potential cation channel, subfamily C, member 3 | 1352 | 0.079 | 0.2800 | Yes |
20 | P2RX7 | P2RX7 Entrez,  Source | purinergic receptor P2X, ligand-gated ion channel, 7 | 1500 | 0.075 | 0.2833 | Yes |
21 | TRPV2 | TRPV2 Entrez,  Source | transient receptor potential cation channel, subfamily V, member 2 | 1634 | 0.072 | 0.2872 | Yes |
22 | CACNA1H | CACNA1H Entrez,  Source | calcium channel, voltage-dependent, alpha 1H subunit | 1737 | 0.069 | 0.2928 | Yes |
23 | SCNN1G | SCNN1G Entrez,  Source | sodium channel, nonvoltage-gated 1, gamma | 1742 | 0.069 | 0.3058 | Yes |
24 | CACNA1C | CACNA1C Entrez,  Source | calcium channel, voltage-dependent, L type, alpha 1C subunit | 1939 | 0.064 | 0.3034 | Yes |
25 | CFTR | CFTR Entrez,  Source | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 1946 | 0.064 | 0.3152 | Yes |
26 | SCN4B | SCN4B Entrez,  Source | sodium channel, voltage-gated, type IV, beta | 1965 | 0.063 | 0.3262 | Yes |
27 | CHRNB2 | CHRNB2 Entrez,  Source | cholinergic receptor, nicotinic, beta 2 (neuronal) | 2101 | 0.060 | 0.3276 | Yes |
28 | KCNK3 | KCNK3 Entrez,  Source | potassium channel, subfamily K, member 3 | 2132 | 0.059 | 0.3368 | Yes |
29 | SCNN1B | SCNN1B Entrez,  Source | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | 2267 | 0.056 | 0.3375 | Yes |
30 | CACNA1S | CACNA1S Entrez,  Source | calcium channel, voltage-dependent, L type, alpha 1S subunit | 2440 | 0.053 | 0.3348 | Yes |
31 | TRPV1 | TRPV1 Entrez,  Source | transient receptor potential cation channel, subfamily V, member 1 | 2478 | 0.052 | 0.3421 | Yes |
32 | CACNB3 | CACNB3 Entrez,  Source | calcium channel, voltage-dependent, beta 3 subunit | 2538 | 0.051 | 0.3475 | Yes |
33 | CACNA1E | CACNA1E Entrez,  Source | calcium channel, voltage-dependent, alpha 1E subunit | 2545 | 0.051 | 0.3568 | Yes |
34 | KCNH3 | KCNH3 Entrez,  Source | potassium voltage-gated channel, subfamily H (eag-related), member 3 | 2561 | 0.050 | 0.3655 | Yes |
35 | BSND | BSND Entrez,  Source | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | 2593 | 0.050 | 0.3728 | Yes |
36 | MS4A2 | MS4A2 Entrez,  Source | membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) | 2608 | 0.050 | 0.3814 | Yes |
37 | KCNH4 | KCNH4 Entrez,  Source | potassium voltage-gated channel, subfamily H (eag-related), member 4 | 2628 | 0.049 | 0.3895 | Yes |
38 | KCNMB1 | KCNMB1 Entrez,  Source | potassium large conductance calcium-activated channel, subfamily M, beta member 1 | 2672 | 0.049 | 0.3957 | Yes |
39 | KCNK15 | KCNK15 Entrez,  Source | potassium channel, subfamily K, member 15 | 2726 | 0.048 | 0.4009 | Yes |
40 | AQP5 | AQP5 Entrez,  Source | aquaporin 5 | 3113 | 0.041 | 0.3797 | Yes |
41 | CACNA1D | CACNA1D Entrez,  Source | calcium channel, voltage-dependent, L type, alpha 1D subunit | 3122 | 0.041 | 0.3871 | Yes |
42 | CACNG5 | CACNG5 Entrez,  Source | calcium channel, voltage-dependent, gamma subunit 5 | 3203 | 0.040 | 0.3888 | Yes |
43 | KCNK10 | KCNK10 Entrez,  Source | potassium channel, subfamily K, member 10 | 3239 | 0.040 | 0.3938 | Yes |
44 | KCNA2 | KCNA2 Entrez,  Source | potassium voltage-gated channel, shaker-related subfamily, member 2 | 3251 | 0.039 | 0.4006 | Yes |
45 | KCNH2 | KCNH2 Entrez,  Source | potassium voltage-gated channel, subfamily H (eag-related), member 2 | 3257 | 0.039 | 0.4078 | Yes |
46 | CNGA3 | CNGA3 Entrez,  Source | cyclic nucleotide gated channel alpha 3 | 3305 | 0.038 | 0.4116 | Yes |
47 | KCNS1 | KCNS1 Entrez,  Source | potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 | 3324 | 0.038 | 0.4176 | Yes |
48 | KCNK1 | KCNK1 Entrez,  Source | potassium channel, subfamily K, member 1 | 3345 | 0.037 | 0.4234 | Yes |
49 | KCNN4 | KCNN4 Entrez,  Source | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | 3482 | 0.035 | 0.4200 | Yes |
50 | CACNA1A | CACNA1A Entrez,  Source | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 3570 | 0.034 | 0.4200 | Yes |
51 | KCNE2 | KCNE2 Entrez,  Source | potassium voltage-gated channel, Isk-related family, member 2 | 3669 | 0.033 | 0.4190 | Yes |
52 | SCN5A | SCN5A Entrez,  Source | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | 3775 | 0.032 | 0.4171 | Yes |
53 | TRPM1 | TRPM1 Entrez,  Source | transient receptor potential cation channel, subfamily M, member 1 | 3784 | 0.031 | 0.4226 | Yes |
54 | KCNC3 | KCNC3 Entrez,  Source | potassium voltage-gated channel, Shaw-related subfamily, member 3 | 3788 | 0.031 | 0.4285 | Yes |
55 | KCND3 | KCND3 Entrez,  Source | potassium voltage-gated channel, Shal-related subfamily, member 3 | 3813 | 0.031 | 0.4326 | Yes |
56 | SCN7A | SCN7A Entrez,  Source | sodium channel, voltage-gated, type VII, alpha | 3851 | 0.030 | 0.4357 | Yes |
57 | KCNA1 | KCNA1 Entrez,  Source | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 3853 | 0.030 | 0.4415 | Yes |
58 | KCNA6 | KCNA6 Entrez,  Source | potassium voltage-gated channel, shaker-related subfamily, member 6 | 3892 | 0.030 | 0.4444 | Yes |
59 | KCNA5 | KCNA5 Entrez,  Source | potassium voltage-gated channel, shaker-related subfamily, member 5 | 3911 | 0.030 | 0.4488 | Yes |
60 | CACNG1 | CACNG1 Entrez,  Source | calcium channel, voltage-dependent, gamma subunit 1 | 3925 | 0.029 | 0.4535 | Yes |
61 | CACNA1G | CACNA1G Entrez,  Source | calcium channel, voltage-dependent, alpha 1G subunit | 3937 | 0.029 | 0.4583 | Yes |
62 | CHRNA6 | CHRNA6 Entrez,  Source | cholinergic receptor, nicotinic, alpha 6 | 4014 | 0.028 | 0.4580 | Yes |
63 | KCNMB4 | KCNMB4 Entrez,  Source | potassium large conductance calcium-activated channel, subfamily M, beta member 4 | 4059 | 0.028 | 0.4601 | Yes |
64 | KCNQ2 | KCNQ2 Entrez,  Source | potassium voltage-gated channel, KQT-like subfamily, member 2 | 4151 | 0.026 | 0.4583 | No |
65 | TRPC5 | TRPC5 Entrez,  Source | transient receptor potential cation channel, subfamily C, member 5 | 4328 | 0.024 | 0.4497 | No |
66 | GLRA1 | GLRA1 Entrez,  Source | glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man syndrome) | 4330 | 0.024 | 0.4543 | No |
67 | FXYD3 | FXYD3 Entrez,  Source | FXYD domain containing ion transport regulator 3 | 4367 | 0.024 | 0.4561 | No |
68 | FXYD1 | FXYD1 Entrez,  Source | FXYD domain containing ion transport regulator 1 (phospholemman) | 4502 | 0.022 | 0.4502 | No |
69 | CHRNA2 | CHRNA2 Entrez,  Source | cholinergic receptor, nicotinic, alpha 2 (neuronal) | 4515 | 0.022 | 0.4535 | No |
70 | P2RX3 | P2RX3 Entrez,  Source | purinergic receptor P2X, ligand-gated ion channel, 3 | 4544 | 0.021 | 0.4555 | No |
71 | ACCN4 | ACCN4 Entrez,  Source | amiloride-sensitive cation channel 4, pituitary | 4630 | 0.020 | 0.4530 | No |
72 | TRPC4 | TRPC4 Entrez,  Source | transient receptor potential cation channel, subfamily C, member 4 | 4722 | 0.019 | 0.4499 | No |
73 | HTR3A | HTR3A Entrez,  Source | 5-hydroxytryptamine (serotonin) receptor 3A | 4785 | 0.019 | 0.4488 | No |
74 | KCNJ3 | KCNJ3 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 3 | 4792 | 0.019 | 0.4520 | No |
75 | KCNH1 | KCNH1 Entrez,  Source | potassium voltage-gated channel, subfamily H (eag-related), member 1 | 4830 | 0.018 | 0.4527 | No |
76 | GLRA2 | GLRA2 Entrez,  Source | glycine receptor, alpha 2 | 4835 | 0.018 | 0.4559 | No |
77 | KCNA3 | KCNA3 Entrez,  Source | potassium voltage-gated channel, shaker-related subfamily, member 3 | 4844 | 0.018 | 0.4588 | No |
78 | KCNQ3 | KCNQ3 Entrez,  Source | potassium voltage-gated channel, KQT-like subfamily, member 3 | 4990 | 0.016 | 0.4510 | No |
79 | KCNS3 | KCNS3 Entrez,  Source | potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 | 5174 | 0.014 | 0.4398 | No |
80 | KCNA4 | KCNA4 Entrez,  Source | potassium voltage-gated channel, shaker-related subfamily, member 4 | 5299 | 0.013 | 0.4329 | No |
81 | AQP8 | AQP8 Entrez,  Source | aquaporin 8 | 5336 | 0.012 | 0.4325 | No |
82 | NMUR2 | NMUR2 Entrez,  Source | neuromedin U receptor 2 | 5367 | 0.012 | 0.4325 | No |
83 | SCN11A | SCN11A Entrez,  Source | sodium channel, voltage-gated, type XI, alpha | 5399 | 0.011 | 0.4323 | No |
84 | CACNG4 | CACNG4 Entrez,  Source | calcium channel, voltage-dependent, gamma subunit 4 | 5484 | 0.010 | 0.4280 | No |
85 | SCN4A | SCN4A Entrez,  Source | sodium channel, voltage-gated, type IV, alpha | 5567 | 0.009 | 0.4236 | No |
86 | RYR1 | RYR1 Entrez,  Source | ryanodine receptor 1 (skeletal) | 5589 | 0.009 | 0.4238 | No |
87 | PDPN | PDPN Entrez,  Source | podoplanin | 5603 | 0.009 | 0.4246 | No |
88 | CLCN2 | CLCN2 Entrez,  Source | chloride channel 2 | 5847 | 0.006 | 0.4074 | No |
89 | KCNIP2 | KCNIP2 Entrez,  Source | Kv channel interacting protein 2 | 5898 | 0.006 | 0.4047 | No |
90 | CHRNA4 | CHRNA4 Entrez,  Source | cholinergic receptor, nicotinic, alpha 4 | 5906 | 0.005 | 0.4052 | No |
91 | KCNJ15 | KCNJ15 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 15 | 6003 | 0.005 | 0.3988 | No |
92 | KCNE1 | KCNE1 Entrez,  Source | potassium voltage-gated channel, Isk-related family, member 1 | 6053 | 0.004 | 0.3959 | No |
93 | P2RX2 | P2RX2 Entrez,  Source | purinergic receptor P2X, ligand-gated ion channel, 2 | 6139 | 0.003 | 0.3901 | No |
94 | SCN9A | SCN9A Entrez,  Source | sodium channel, voltage-gated, type IX, alpha | 6177 | 0.003 | 0.3878 | No |
95 | KCNG2 | KCNG2 Entrez,  Source | potassium voltage-gated channel, subfamily G, member 2 | 6206 | 0.002 | 0.3861 | No |
96 | KCNJ5 | KCNJ5 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 5 | 6426 | -0.000 | 0.3696 | No |
97 | SCN1B | SCN1B Entrez,  Source | sodium channel, voltage-gated, type I, beta | 6455 | -0.000 | 0.3675 | No |
98 | CACNB2 | CACNB2 Entrez,  Source | calcium channel, voltage-dependent, beta 2 subunit | 6462 | -0.000 | 0.3671 | No |
99 | CACNA1B | CACNA1B Entrez,  Source | calcium channel, voltage-dependent, L type, alpha 1B subunit | 6647 | -0.002 | 0.3537 | No |
100 | CHRNE | CHRNE Entrez,  Source | cholinergic receptor, nicotinic, epsilon | 6825 | -0.004 | 0.3411 | No |
101 | KCNC1 | KCNC1 Entrez,  Source | potassium voltage-gated channel, Shaw-related subfamily, member 1 | 6848 | -0.004 | 0.3402 | No |
102 | KCNQ1 | KCNQ1 Entrez,  Source | potassium voltage-gated channel, KQT-like subfamily, member 1 | 6895 | -0.005 | 0.3376 | No |
103 | CHRNB4 | CHRNB4 Entrez,  Source | cholinergic receptor, nicotinic, beta 4 | 7214 | -0.008 | 0.3151 | No |
104 | CHRND | CHRND Entrez,  Source | cholinergic receptor, nicotinic, delta | 7510 | -0.011 | 0.2948 | No |
105 | CACNB4 | CACNB4 Entrez,  Source | calcium channel, voltage-dependent, beta 4 subunit | 7521 | -0.011 | 0.2961 | No |
106 | CHRNA1 | CHRNA1 Entrez,  Source | cholinergic receptor, nicotinic, alpha 1 (muscle) | 7580 | -0.011 | 0.2939 | No |
107 | KCNJ10 | KCNJ10 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 10 | 7799 | -0.014 | 0.2801 | No |
108 | CNGB1 | CNGB1 Entrez,  Source | cyclic nucleotide gated channel beta 1 | 7881 | -0.014 | 0.2767 | No |
109 | CHRNB3 | CHRNB3 Entrez,  Source | cholinergic receptor, nicotinic, beta 3 | 8039 | -0.016 | 0.2680 | No |
110 | CLCA2 | CLCA2 Entrez,  Source | chloride channel, calcium activated, family member 2 | 8169 | -0.017 | 0.2615 | No |
111 | KCNJ1 | KCNJ1 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 1 | 8394 | -0.020 | 0.2484 | No |
112 | KCNJ12 | KCNJ12 Entrez,  Source | potassium inwardly-rectifying channel, subfamily J, member 12 | 8416 | -0.020 | 0.2507 | No |
113 | GLRB | GLRB Entrez,  Source | glycine receptor, beta | 8597 | -0.022 | 0.2413 | No |
114 | AQP7 | AQP7 Entrez,  Source | aquaporin 7 | 8603 | -0.022 | 0.2451 | No |
115 | CACNB1 | CACNB1 Entrez,  Source | calcium channel, voltage-dependent, beta 1 subunit | 8689 | -0.023 | 0.2431 | No |
116 | KCNN2 | KCNN2 Entrez,  Source | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 | 8839 | -0.024 | 0.2365 | No |
117 | P2RX4 | P2RX4 Entrez,  Source | purinergic receptor P2X, ligand-gated ion channel, 4 | 9274 | -0.029 | 0.2093 | No |
118 | AQP6 | AQP6 Entrez,  Source | aquaporin 6, kidney specific | 9826 | -0.035 | 0.1744 | No |
119 | TRPV6 | TRPV6 Entrez,  Source | transient receptor potential cation channel, subfamily V, member 6 | 10024 | -0.037 | 0.1668 | No |
120 | TRPM2 | TRPM2 Entrez,  Source | transient receptor potential cation channel, subfamily M, member 2 | 10275 | -0.040 | 0.1557 | No |
121 | HTR3B | HTR3B Entrez,  Source | 5-hydroxytryptamine (serotonin) receptor 3B | 10347 | -0.041 | 0.1583 | No |
122 | CLCN3 | CLCN3 Entrez,  Source | chloride channel 3 | 10689 | -0.046 | 0.1414 | No |
123 | TRPC1 | TRPC1 Entrez,  Source | transient receptor potential cation channel, subfamily C, member 1 | 11504 | -0.060 | 0.0916 | No |
124 | AQP2 | AQP2 Entrez,  Source | aquaporin 2 (collecting duct) | 11513 | -0.061 | 0.1027 | No |
125 | CUL5 | CUL5 Entrez,  Source | cullin 5 | 11698 | -0.065 | 0.1013 | No |
126 | P2RX5 | P2RX5 Entrez,  Source | purinergic receptor P2X, ligand-gated ion channel, 5 | 12877 | -0.118 | 0.0352 | No |